InvestorsHub on MSN
Eli Lilly shares rise after retatrutide delivers striking weight-loss and pain-relief results in phase 3 study
Eli Lilly (NYSE:LLY) climbed 3% in premarket trading Thursday after unveiling landmark Phase 3 data for its experimental ...
Eli Lilly has unveiled a new weight loss drug that appears to be delivering the highest weight loss yet in clinical trials ...
Daily Voice on MSN
WHO Endorses GLP-1 Weight-Loss Drugs In New Guidelines: Here's Why
The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new ...
Weight loss drugs like Ozempic have ‘little’ effect on obesity-linked cancers, researchers find - Some of the nation’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback